ono-7475
Small moleculeexperimental
Clinical trial activity
4 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jun 30, 2017 (NCT03176277)
Timeline
2010s
- Jan 1, 2017
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
MERTK inhibitor
- Tyrosine-protein kinase receptor UFOINHIBITOR
AXL inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- ono-7475
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06532331 | Phase 1 | Dec 6, 2023 | Ono Pharmaceuticals |
| NCT06525246 | Phase 1 | Aug 6, 2021 | Ono Pharmaceuticals |
| NCT03730337 | Phase 1 | Oct 17, 2018 | Ono Pharmaceuticals |
| NCT03176277 | Phase 1 | Jun 30, 2017 | Ono Pharmaceuticals |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Ono Pharmaceuticals | For profit | 4 | 4 | 1 | 2017 |
1 organizations
Page 1 / 1